HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


'For Sale' Signs In Consumer Health Sector As Firms Sharpen Pharma Focus

This article was originally published in The Rose Sheet

Executive Summary

Freeing up spending for their Rx businesses prompt Merck KGAA to look at selling its division marketing Nasivin OTC nasal sprays, Omnibionta probiotic vitamins and other brands, and Pfizer to shop its consumer business with Advil analgesics, Centrum multivitamins and other OTC and dietary supplement brands.


Related Content

With Its Own Home, Pfizer Consumer Health Gets Higher Profile For Sale
Reckitt Benckiser Gives Consumer Health Portfolio Its Own Home – What's Next?
Pfizer Déjà Vu: Is It Time To Sell The Consumer Health Business?
Big Pharma Set To Compete For German Merck's Consumer Health Unit
GSK Trims Nutritional Drink Lines, Wants All Of Its Consumer JV Pie
Glaxo And Novartis Scratch Each Other’s Back With Consumer Product JV


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts